Gara Jalqabaatti › Limfomaa T-Selii
Qorannoo klinikaalii Limfomaa T-Selii Ameerikaa Keessatti hirmaatuu
Qorannoo 36 Limfomaa T-Selii f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- New York City, NYQorannoo 13
- Philadelphia, PAQorannoo 10
- Baldwin Park, CAQorannoo 9
- Boston, MAQorannoo 9
- Houston, TXQorannoo 8
- Atlanta, GAQorannoo 8
- Rochester, MNQorannoo 6
- Columbus, OHQorannoo 6
- Chicago, ILQorannoo 6
- Seattle, WAQorannoo 6
- New Haven, CTQorannoo 5
- Miami, FLQorannoo 5
- Scottsdale, AZQorannoo 4
- St. Louis, MOQorannoo 4
- Durham, NCQorannoo 4
- Cedar Rapids, IAQorannoo 4
- Portland, ORQorannoo 4
- Ann Arbor, MIQorannoo 4
- Baltimore, MDQorannoo 4
- Charlottesville, VAQorannoo 4
- San Diego, CAQorannoo 3
- Charlotte, NCQorannoo 3
- Washington, DCQorannoo 3
- Aurora, COQorannoo 3
- East Norwalk, CTQorannoo 3
- Omaha, NEQorannoo 3
- Edison, NJQorannoo 3
- Staten Island, NYQorannoo 3
- New Rochelle, NYQorannoo 3
- Tampa, FLQorannoo 3
- San Francisco, CAQorannoo 3
- Queens, NYQorannoo 3
- Denver, COQorannoo 3
- Madison, WIQorannoo 3
- Minneapolis, MNQorannoo 3
- Salt Lake City, UTQorannoo 3
- Los Angeles, CAQorannoo 3
- Cincinnati, OHQorannoo 3
- Milwaukee, WIQorannoo 3
- Indianapolis, INQorannoo 3
Naannoon
- ArizonaQorannoo 5
- CaliforniaQorannoo 13
- ColoradoQorannoo 6
- ConnecticutQorannoo 5
- FloridaQorannoo 8
- GeorgiaQorannoo 8
- IllinoisQorannoo 7
- IndianaQorannoo 3
- IowaQorannoo 4
- MarylandQorannoo 5
- MassachusettsQorannoo 9
- MichiganQorannoo 5
- MinnesotaQorannoo 9
- MissouriQorannoo 4
- NebraskaQorannoo 3
- New JerseyQorannoo 4
- New YorkQorannoo 15
- North CarolinaQorannoo 6
- OhioQorannoo 8
- OklahomaQorannoo 3
- OregonQorannoo 4
- PennsylvaniaQorannoo 12
- TexasQorannoo 9
- UtahQorannoo 3
- VirginiaQorannoo 5
- WashingtonQorannoo 6
- WisconsinQorannoo 5
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07388563Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04234048Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04803201Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06561048BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT04752826Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT06724237A Study of Ruxolitinib and Duvelisib in People With Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT05010005A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06854653A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT04104776Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT07382817Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 18 · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06390319CD45BE-HSPC + CART-45 Cells
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT07451054Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07750886Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07293403Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT03011814Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 0 hanga 29 · Saalaa hunda · Haaromfame 07-Ado-2026 · NCT06934382Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT03501576Allo HSCT Using RIC and PTCy for Hematological Diseases
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 75 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT05805605Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ado-2026 · NCT06508463CD4CAR for CD4+ Leukemia and Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 24-Wax-2026 · NCT03829540A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Wax-2026 · NCT05463263Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT05313243A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT03017820Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Wax-2026 · NCT07278856Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.